Valuation: Hypera S.A.

Market Cap 14.9B 2.89B 2.47B 2.31B 2.12B 3.98B 276B 4.03B 27.35B 10.67B 139B 10.84B 10.61B 459B P/E 2026 *
7.79x
P/E 2027 * 6.57x
Enterprise Value 21.02B 4.07B 3.49B 3.27B 2.99B 5.61B 390B 5.68B 38.58B 15.04B 196B 15.3B 14.96B 648B EV / Sales 2026 *
2.29x
EV / Sales 2027 * 2.03x
Free-Float
38.88%
Yield 2026 *
5.56%
Yield 2027 * 5.28%
1 day-1.15%
1 week+2.63%
Current month+2.87%
1 month+7.63%
3 months-2.49%
6 months-2.27%
Current year+3.93%
1 week 3.96
Extreme 3.96
4.3
1 month 3.75
Extreme 3.75
4.3
Current year 3.75
Extreme 3.75
5.5
1 year 3.71
Extreme 3.71
5.5
3 years 2.64
Extreme 2.64
8.38
5 years 2.64
Extreme 2.64
10.08
10 years 2.64
Extreme 2.64
11.98
Manager TitleAgeSince
Chief Executive Officer 50 24/04/2019
Director of Finance/CFO 38 24/02/2022
Chief Operating Officer 40 01/01/2020
Director TitleAgeSince
Director/Board Member 77 01/06/2007
Director/Board Member 60 01/06/2007
Director/Board Member 52 26/03/2007
Change 5-day change 1-year change 3-year change Capi.($)
-1.15%+2.63% - - 2.89B
+0.88%+6.38%+76.40%+126.75% 1,119B
+1.07%+3.80%+50.73%+62.78% 651B
+1.20%+6.21%+25.81%+78.74% 468B
+1.02%+5.77%+43.63%+48.43% 374B
+0.85%+4.07%+24.97%+40.58% 302B
+1.26%+6.81%+2.27%+14.41% 259B
+1.88%+5.81%+49.57%+70.53% 238B
+1.59%+2.09%-17.33%-52.62% 208B
+1.87%+5.61%+27.32%+91.38% 181B
Average +1.05%+4.97%+31.49%+53.44% 422.21B
Weighted average by Cap. +1.14%+5.09%+44.26%+72.65%

Financials

2026 *2027 *
Net sales 9.2B 1.78B 1.53B 1.43B 1.31B 2.45B 171B 2.49B 16.88B 6.58B 85.68B 6.69B 6.55B 283B 10B 1.94B 1.66B 1.55B 1.42B 2.67B 185B 2.7B 18.35B 7.16B 93.14B 7.28B 7.12B 308B
Net income 1.91B 370M 317M 297M 272M 510M 35.45B 517M 3.51B 1.37B 17.81B 1.39B 1.36B 58.9B 2.22B 431M 369M 346M 316M 594M 41.25B 602M 4.08B 1.59B 20.72B 1.62B 1.58B 68.55B
Net Debt 6.12B 1.19B 1.02B 951M 870M 1.63B 113B 1.65B 11.23B 4.38B 57B 4.45B 4.36B 189B 5.35B 1.04B 889M 831M 761M 1.43B 99.26B 1.45B 9.82B 3.83B 49.86B 3.9B 3.81B 165B
Logo Hypera S.A.
Hypera (formerly Hypermarcas) is the Brazilian leader in the manufacture and marketing of pharmaceutical products. The products are sold primarily under the Addera D3, Adocyl, AdultMax, Alivium, Apracur, Atroveran, Benegrip, Bigfral, Biotonico Fontoura, Coristina, Cremer, Doril, Engov, Epocler, Lisador and Neo Quimica. The activity is organized around 3 families of products : - OTC medicines; - prescription medicines; - branded generic medicines.
Employees
10,564
Date Price Change Volume
21/08/26 $4.100 +1.23% 944
20/08/26 $4.050 -0.25% 5,648
19/08/26 $4.060 +1.75% 6,530
18/08/26 $3.990 -3.62% 2,258
17/08/26 $4.140 -1.19% 1,021
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
21.17BRL
Average target price
29.17BRL
Spread / Average Target
+37.77%

Quarterly revenue - Rate of surprise